Michael D Abramoff MD

Retinal Disease

Ophthalmology

200 Hawkins DrIowa City, IA 52242
Phone+1 319-356-3938
Fax+1 319-353-7699

Dr. Abramoff is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abramoff's full profile Already have an account?

Education & Training

University of Amsterdam Faculty of MedicineClass of 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IA State Medical License 2004 - 2027

Clinical Trials

Retinal Vessel Measurements as Clinically Useful Predictors in Veterans Start of enrollment: 2013 Feb 01
COMPLETED

Publications & Presentations

PubMed

Ethics of Autonomous AI Clinical Trials: Delphi Study.
Ariadne A Nichol, Alaa Youssef, David B Larson, Michael Abramoff, Risa M Wolf
Journal of Medical Internet Research. 2026-08-21
Neuroretinal Layer Thinning on OCT Imaging and Hemoglobin A1c in Youth With Type 1 Diabetes.
Supriya Ramanujam, Roomasa Channa, T Y Alvin Liu, Elizabeth A Brown, Neha Parimi
JAMA Ophthalmology. 2026-08-01
Reference Standard for Validation of Age-Related Macular Degeneration Screening Algorithms.
Amitha Domalpally, Emily Y Chew, Malvina B Eydelman, Tiarnán D L Keenan, Pearse A Keane
Ophthalmology. 2026-07-01

Journal Articles

Cost-Effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients with Diabetes
Michael Abramoff, MD, JAMA Ophthalmology

Press Mentions

Can AI Close the Diabetic Retinopathy Screening Gap?February 1st, 2026
Nation’s Eye Physicians, Researchers Launch Campaign to Protect America’s Standing as World Leader in Vision ResearchJuly 23rd, 2025
Op-Ed: Congress Must Not Dismantle America's Vision Research Crown JewelFebruary 10th, 2025

Grant Support

Computer Aided Detection Of Diabetic Retinopathy In Veterans With DiabetesVeterans Affairs2012
Retinal Therapy Guided By 3-D OCT Image AnalysisNational Eye Institute2010–2012
Focal Structure-Function Relationships In Macular Layers From 3D Spectral OCTNational Eye Institute2009–2011
Computer Aided Detection Of Diabetic Retinopathy In Veterans With DiabetesClinical Science Research &Development2009
Low-Cost, Portable, Computer Assisted Imaging For Diabe*National Eye Institute2005–2008